| FOR IMMEDIATE RELEASE |
||
| Date: Contact | July 23 , 2004 Matt Andrus (603) 352-3810, ext. 3251 matt_andrus@schleicher-schuell.com |
|
| Schleicher & Schuell BioScience and KREATECH Biotechnology Ink Supply and Marketing License Agreement | ||
| Sanford, ME, USA and Amsterdam, the Netherlands – July 23, 2004. Schleicher & Schuell BioScience, Inc. and KREATECH Biotechnology BV announce signing of an agreement for incorporation of Kreatech’s patented Universal Linkage System (ULS™) into Schleicher & Schuell’s new Two Color Labeling and Fluorescent Detection Kit. The S&S® Two Color Labeling and Fluorescent Detection Kit is intended for use with the recently launched S&S Serum Biomarker Chip. The S&S Serum Biomarker Chip contains 120 different antibodies spotted on S&S FAST® Slides, and is intended for rapid profiling of known serum biomarkers. Each serum sample applied to the Serum Biomarker Chip is labeled with either ULS-biotin or ULS-fluorescein, then pooled and probed against the antibody microarray in a competitive binding fashion. The bound labeled serum proteins are detected using fluorescent Dy™ dyes from Dyomics GmbH using either a streptavidin-Dy™647 conjugate or an anti-fluorescein antibody-Dy™547 conjugate. The processed microarray is scanned at two different wavelengths on a standard two-color fluorescent scanner. KREATECH, holder of a license from Dyomics GmbH (Jena, Germany), has sub-licensed the use of the Dyomics dye conjugates to Schleicher & Schuell for use in its protein array products and services. The use of the ULS labeling system minimizes background using indirect fluorescence detection, labels multiple amino acids, and is ready to use, as it requires no need to purchase additional materials .“S&S has broken through the density limitation of antibody chips through the use of KREATECH’s ULS protein labeling system. This is another example of how S&S is delivering on the promise of high density antibody chips and addresses high-throughput technology needs in cancer research” said Robert Negm, PhD, Director, Business Development at S&S. “We are very pleased to have our first ULS license agreement for protein labeling in place with a company as renowned as Schleicher & Schuell BioScience. With their high density antibody chips based on the FAST Slides platform, S&S is well-positioned to play a leading role in the proteomics market and to put our proprietary ULS-platform on the map for protein labeling applications. This agreement further consolidates KREATECH's leading position when it comes to a novel approach in labeling of biomolecules”, said Alexander Altink, Chief Executive Officer of KREATECH. . |
About Schleicher & Schuell BioScience, Inc. About KREATECH Biotechnology B.V.
Robert S. Negm, PhD |
© 2004 Schleicher & Schuell BioScience